C07K 16/2866
Against receptors for cytokines, lymphokines, interferons
Official title: {against receptors for cytokines, lymphokines, interferons}
C07K16/2866 (Against receptors for cytokines, lymphokines, interferons) appears on 2,456 US grants and 4,736 published applications in this corpus.
Search patents in C07K- Granted patents
- 2,456
- Published applications
- 4,736
- Assignees
- 1,202
- Inventors
- 7,097
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 15 | 0 |
| 1997 | 13 | 0 |
| 1998 | 32 | 0 |
| 1999 | 44 | 0 |
| 2000 | 18 | 0 |
| 2001 | 26 | 5 |
| 2002 | 31 | 76 |
| 2003 | 31 | 70 |
| 2004 | 32 | 87 |
| 2005 | 20 | 91 |
| 2006 | 29 | 86 |
| 2007 | 22 | 121 |
| 2008 | 45 | 75 |
| 2009 | 64 | 125 |
| 2010 | 73 | 157 |
| 2011 | 74 | 158 |
| 2012 | 88 | 136 |
| 2013 | 102 | 148 |
| 2014 | 94 | 185 |
| 2015 | 100 | 158 |
| 2016 | 113 | 209 |
| 2017 | 123 | 199 |
| 2018 | 133 | 248 |
| 2019 | 118 | 243 |
| 2020 | 136 | 275 |
| 2021 | 138 | 293 |
| 2022 | 138 | 313 |
| 2023 | 129 | 321 |
| 2024 | 177 | 368 |
| 2025 | 157 | 319 |
| 2026 | 119 | 270 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inducible chimeric antigen receptor and application thereof6 Oct 2026US 12,752,007 B2Beijing Tiantan Hospital, Capital Medical University
- CCR4 targeted chimeric antigen receptor modified T cells for treatment of CCR4 positive malignancies6 Oct 2026US 12,753,219 B2City of Hope
- Anti-CD123 antibodies, anti-CD123 chimeric antigen receptors and anti-CD123 chimeric antigen receptors T cells29 Sep 2026US 12,747,295 B2Centre Hospitalier Regional Universitaire De Besancon
- Anti-CCR8 antibodies for treating cancer29 Sep 2026US 12,747,296 B2Bristol-Myers Squibb Company
- Bispecific antibody simultaneously binding to interleukin-4 receptor alpha subunit and interleukin-5 receptor alpha subunit, encoding nucleic acids thereof and methods of use thereof for treatment29 Sep 2026US 12,747,297 B2Ajou University Industry-Academic Cooperation Foundation
- Methods for treating or preventing asthma by administering an il-4r antagonist8 Oct 2026US 2026/0306627 A1Regeneron Pharmaceuticals, Inc.
- Colony stimulating factor 1 receptor antibodies and methods of use thereof8 Oct 2026US 2026/0308263 A1Otsuka Pharmaceutical Co., Ltd.
- Il-5raxcd3e t cell engaging bispecific antibody and uses thereof8 Oct 2026US 2026/0308264 A1Ajou University Industry-Academic Cooperation Foundation
- Il12rb2 binding molecules and methods of use8 Oct 2026US 2026/0308265 A1Synthekine, Inc.
- Methods and means for the production of ig-like molecules8 Oct 2026US 2026/0308655 A1Merus N.V.
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Humanized immunoglobulins and methods of making the same1,467US 6,180,370 B2Protein Design Labs, Inc. · 2001
- Production of chimeric antibodies - a combinatorial approach1,367US 5,565,332 ACambridge Antibody Technology Limited · 1996